Clinical Trial Update: Study of PF-04523655 (REDD14NP) In Subjects With Choroidal Neovascularization (CNV) Secondary to Age-Related Macular Degeneration (Wet AMD) [Phase 1]

View source ↗

Summary

Phase 1 trial update of PF-04523655 (REDD14NP) in patients with choroidal neovascularization secondary to wet age-related macular degeneration; study status is …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration

Drugs mentioned

• PF-04523655 (REDD14NP) (PF-04523655)

Snippet

Sponsor: Quark Pharmaceuticals | Conditions: Age-Related Macular Degeneration | Phase 1 | Status: COMPLETED